sugammadex
NDC 68462-695, sugammadex, injection, solution, from GLENMARK PHARMACEUTICALS INC., USA.
- Product NDC
- 68462-695
- Status
- Listed
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214364
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-695 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUGAMMADEX SODIUM200 mg/2mL
Pharmacologic classes
gamma-Cyclodextrins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-695-20 | 68462069520 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68462-695-20) / 2 mL in 1 VIAL, SINGLE-DOSE (68462-695-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e7897fc1-4553-460c-a29b-0bc91cd9ca10
Use it
Look up 68462-695 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-695 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-695. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.